INNOVATE BIOPHARMACEUTICALS (INNT) earnings
Quarterly and annual INNT reports and results, each read against the price at its own news timestamp. Back to the INNT overview →
No INNT earnings events in the measured window.
Nothing matched in the current window — the INNT overview has every event we measure for this name.
Get an email when INNT moves on news →Keep exploring
More INNT: analyst actions → · SEC filings → · INNT overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Atossa Therapeutics, Inc. (ATOS) | 222 | -0.02% | 48% |
| FibroGen, Inc (FGEN) | 220 | -0.50% | 45% |
| OWC PHARMS RESEARCH CORP (OWCP) | 220 | +0.09% | 52% |
| PROVECTUS BIOPHARMS (PVCT) | 220 | +0.01% | 50% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.